Bernard et al, Supplementary Figure S4

Bernard et al, Supplementary Figure S4 pTRE pTRIP-DU3-TRE-MCS Supplementary Figure S4. The pTRIP-DU3-TRE-MCS lentivector. The lentivector pTRIP-DU3-TRE-MCS was derived from the self-inactivating lentivectorpTRIP-DU3-EF1a-EGFP (1). The EF1a promoter was replaced by the tetracycline-inducible pTRE promoter from the vector pTRE-tight (Clontech) and a multiple cloning site (MCS) was inserted in place of the GFP gene. The cDNAs coding D133P53a, D133P53b, or D133P53g (XhoII-BamHI fragments), respectively, were subcloned into the SalI-BamHI sites of pTRIP-DU3-TRE-MCS. The resulting lentivector plasmids were pTRIP-TRE-D133P53a, -D133P53b, and -D133P53g . 1. Sirven A, Ravet E, Charneau P, et al. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 2001;3(4):438-48.

Bernard et al, Supplementary Figure S4

Bernard et al, Supplementary Figure S4

Presentation Transcript

Supplementary Figure 4 Hori et al.

Patel et al Supplemental Figure S4

Mertens et al., Supplementary Figure

Supplementary Figure 1 Lewis, et al.

Nakayama et al. , Supplementary Figure 3

Farmer et al Supplementary Figure 1

Supplementary Figure 1. Suzuki et al.

Yoon et al. Supplementary Figure S4

Supplementary Figure S4

Supplementary Figure 1 Logan et al

Supplementary Figure S4

Oiva et al., Supplementary Figure.

Supplementary Figure 5. Nikolova et al

Supplementary Figure 1_Van Looy et al.

Sansone et al, Supplementary Figure 2

Lennon et al. Supplementary Information Figure S4

Supplementary Figure S4

Figure S4 supplementary

Supplementary Figure S4

Figure S4. Yun et al ., 2014